About

Who we are

Diseases do not respect geographical borders and travel as easily as people and products within countries and across continents. Each year, many adults die from vaccine-preventable diseases and many thousands more suffer serious health problems. Vaccines protect us from a variety of common diseases that can be serious and even deadly.
RFS is committed to improving reporting of vaccinations to state immunization registries and encouraging greater utilization of health information technology to track vaccination status and improve patient outcomes and care.
We are committed to improving immunization rates among at-risk populations.

Our history

RFS has begun producing conjugated and unconjugated polysaccharide vaccines, including Hib, Meningitis and pneumococcal vaccines, based on international standards and with a vision to local and international markets. The complete procedure from production until packaging is designed and operated with the worldwide collaborations in this field and under the supervision of leading international technology owners.

Boards of directors

RFS is collaborating with domestic and international universities and research institutes, using the excellent expertise of its team in the following fields: Microbiology, Genetics, Protein Engineering, fermentation and formulation. RFS employs professional researchers and possesses advanced equipment, which have obtained great achievements in production promotion and process engineering.